Attorney and former Ambassador C. Boyden Gray held a press briefing on the phone Wednesday to introduce a new lawsuit being filed against the Food and Drug Administration (FDA) over its claims that ivermectin is an ineffective treatment for COVID-19.
“Tomorrow we will be suing the FDA over its unlawful attempts to interfere with the practice of medicine, specifically, this crusade to halt the use of Ivermectin to treat COVID-19,” said Gray in a conference call with reporters. “This lawsuit is very important to preserve medical freedom and the doctor-patient relationship in the United States.”
“Congress recognized the importance of letting doctors be doctors and expressly prohibited the FDA from interfering with the practice of medicine,” he said. “That is exactly what the FDA has done time and time again throughout this pandemic, assuming authority it doesn’t have and trying to insert itself in the medical decisions of Americans everywhere.”
Ivermectin was approved by the FDA for human use in 1996 and, said Gray, “the drug has long been used off-label to treat numerous diseases.”
Gray, former White House counsel to President George H.W. Bush and founding partner of Boyden Gray & Associates, is representing Drs. Mary Talley Bowden, Paul E. Marik, and Robert L. Apter, who have faced obstructions to their practice due to their promotion of Ivermectin as an effective COVID treatment.
The lawsuit was filed June 2 in the U.S. District Court for the Southern District of Texas, where one of the doctors being represented, Dr. Mary Bowden, resides.
“The FDA generally cannot ban particular uses of human drugs once they are otherwise approved and admitted to the market, even if such use differs from the labeling — commonly referred to as ‘off-label’ use,” states the lawsuit. “The FDA also cannot advise whether a patient should take an approved drug for a particular purpose. Those dec…